2023-10-272024-10-312024-10-31false15242737GKAD HOLDINGS LIMITED2025-09-05falseiso4217:GBPxbrli:pure152427372023-10-26152427372024-10-31152427372023-10-272024-10-31152427372023-10-25152427372023-10-26152427372023-10-262023-10-2615242737bus:SmallEntities2023-10-272024-10-3115242737bus:AuditExempt-NoAccountantsReport2023-10-272024-10-3115242737bus:FullAccounts2023-10-272024-10-3115242737bus:PrivateLimitedCompanyLtd2023-10-272024-10-3115242737core:WithinOneYear2024-10-3115242737core:AfterOneYear2024-10-3115242737core:WithinOneYear2023-10-2615242737core:AfterOneYear2023-10-2615242737core:ShareCapital2024-10-3115242737core:SharePremium2024-10-3115242737core:RevaluationReserve2024-10-3115242737core:OtherReservesSubtotal2024-10-3115242737core:RetainedEarningsAccumulatedLosses2024-10-3115242737core:ShareCapital2023-10-2615242737core:SharePremium2023-10-2615242737core:RevaluationReserve2023-10-2615242737core:OtherReservesSubtotal2023-10-2615242737core:RetainedEarningsAccumulatedLosses2023-10-2615242737core:LandBuildings2024-10-3115242737core:PlantMachinery2024-10-3115242737core:Vehicles2024-10-3115242737core:FurnitureFittings2024-10-3115242737core:OfficeEquipment2024-10-3115242737core:NetGoodwill2024-10-3115242737core:IntangibleAssetsOtherThanGoodwill2024-10-3115242737core:ListedExchangeTraded2024-10-3115242737core:UnlistedNon-exchangeTraded2024-10-3115242737core:LandBuildings2023-10-2615242737core:PlantMachinery2023-10-2615242737core:Vehicles2023-10-2615242737core:FurnitureFittings2023-10-2615242737core:OfficeEquipment2023-10-2615242737core:NetGoodwill2023-10-2615242737core:IntangibleAssetsOtherThanGoodwill2023-10-2615242737core:ListedExchangeTraded2023-10-2615242737core:UnlistedNon-exchangeTraded2023-10-2615242737core:LandBuildings2023-10-272024-10-3115242737core:PlantMachinery2023-10-272024-10-3115242737core:Vehicles2023-10-272024-10-3115242737core:FurnitureFittings2023-10-272024-10-3115242737core:OfficeEquipment2023-10-272024-10-3115242737core:NetGoodwill2023-10-272024-10-3115242737core:IntangibleAssetsOtherThanGoodwill2023-10-272024-10-3115242737core:ListedExchangeTraded2023-10-272024-10-3115242737core:UnlistedNon-exchangeTraded2023-10-272024-10-3115242737core:MoreThanFiveYears2023-10-272024-10-3115242737core:Non-currentFinancialInstruments2024-10-3115242737core:Non-currentFinancialInstruments2023-10-2615242737dpl:CostSales2023-10-272024-10-3115242737dpl:DistributionCosts2023-10-272024-10-3115242737core:LandBuildings2023-10-272024-10-3115242737core:PlantMachinery2023-10-272024-10-3115242737core:Vehicles2023-10-272024-10-3115242737core:FurnitureFittings2023-10-272024-10-3115242737core:OfficeEquipment2023-10-272024-10-3115242737dpl:AdministrativeExpenses2023-10-272024-10-3115242737core:NetGoodwill2023-10-272024-10-3115242737core:IntangibleAssetsOtherThanGoodwill2023-10-272024-10-3115242737dpl:GroupUndertakings2023-10-272024-10-3115242737dpl:ParticipatingInterests2023-10-272024-10-3115242737dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-272024-10-3115242737core:ListedExchangeTraded2023-10-272024-10-3115242737dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-272024-10-3115242737core:UnlistedNon-exchangeTraded2023-10-272024-10-3115242737dpl:CostSales2023-10-262023-10-2615242737dpl:DistributionCosts2023-10-262023-10-2615242737core:LandBuildings2023-10-262023-10-2615242737core:PlantMachinery2023-10-262023-10-2615242737core:Vehicles2023-10-262023-10-2615242737core:FurnitureFittings2023-10-262023-10-2615242737core:OfficeEquipment2023-10-262023-10-2615242737dpl:AdministrativeExpenses2023-10-262023-10-2615242737core:NetGoodwill2023-10-262023-10-2615242737core:IntangibleAssetsOtherThanGoodwill2023-10-262023-10-2615242737dpl:GroupUndertakings2023-10-262023-10-2615242737dpl:ParticipatingInterests2023-10-262023-10-2615242737dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-262023-10-2615242737core:ListedExchangeTraded2023-10-262023-10-2615242737dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-262023-10-2615242737core:UnlistedNon-exchangeTraded2023-10-262023-10-2615242737core:NetGoodwill2024-10-3115242737core:IntangibleAssetsOtherThanGoodwill2024-10-3115242737core:LandBuildings2024-10-3115242737core:PlantMachinery2024-10-3115242737core:Vehicles2024-10-3115242737core:FurnitureFittings2024-10-3115242737core:OfficeEquipment2024-10-3115242737core:AfterOneYear2024-10-3115242737core:WithinOneYear2024-10-3115242737core:ListedExchangeTraded2024-10-3115242737core:UnlistedNon-exchangeTraded2024-10-3115242737core:ShareCapital2024-10-3115242737core:SharePremium2024-10-3115242737core:RevaluationReserve2024-10-3115242737core:OtherReservesSubtotal2024-10-3115242737core:RetainedEarningsAccumulatedLosses2024-10-3115242737core:NetGoodwill2023-10-2615242737core:IntangibleAssetsOtherThanGoodwill2023-10-2615242737core:LandBuildings2023-10-2615242737core:PlantMachinery2023-10-2615242737core:Vehicles2023-10-2615242737core:FurnitureFittings2023-10-2615242737core:OfficeEquipment2023-10-2615242737core:AfterOneYear2023-10-2615242737core:WithinOneYear2023-10-2615242737core:ListedExchangeTraded2023-10-2615242737core:UnlistedNon-exchangeTraded2023-10-2615242737core:ShareCapital2023-10-2615242737core:SharePremium2023-10-2615242737core:RevaluationReserve2023-10-2615242737core:OtherReservesSubtotal2023-10-2615242737core:RetainedEarningsAccumulatedLosses2023-10-2615242737core:NetGoodwill2023-10-2515242737core:IntangibleAssetsOtherThanGoodwill2023-10-2515242737core:LandBuildings2023-10-2515242737core:PlantMachinery2023-10-2515242737core:Vehicles2023-10-2515242737core:FurnitureFittings2023-10-2515242737core:OfficeEquipment2023-10-2515242737core:AfterOneYear2023-10-2515242737core:WithinOneYear2023-10-2515242737core:ListedExchangeTraded2023-10-2515242737core:UnlistedNon-exchangeTraded2023-10-2515242737core:ShareCapital2023-10-2515242737core:SharePremium2023-10-2515242737core:RevaluationReserve2023-10-2515242737core:OtherReservesSubtotal2023-10-2515242737core:RetainedEarningsAccumulatedLosses2023-10-2515242737core:AfterOneYear2023-10-272024-10-3115242737core:WithinOneYear2023-10-272024-10-3115242737core:Non-currentFinancialInstrumentscore:CostValuation2023-10-272024-10-3115242737core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-272024-10-3115242737core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-272024-10-3115242737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-272024-10-3115242737core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-272024-10-3115242737core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-272024-10-3115242737core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-272024-10-3115242737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-272024-10-3115242737core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-272024-10-3115242737core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3115242737core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3115242737core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3115242737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3115242737core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3115242737core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3115242737core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3115242737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3115242737core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3115242737core:Non-currentFinancialInstrumentscore:CostValuation2023-10-2615242737core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-2615242737core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-2615242737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-2615242737core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-2615242737core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-2615242737core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-2615242737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-2615242737core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-2615242737bus:Director12023-10-272024-10-3115242737bus:Director22023-10-272024-10-31

GKAD HOLDINGS LIMITED

Registered Number
15242737
(England and Wales)

Unaudited Financial Statements for the Period ended
31 October 2024

GKAD HOLDINGS LIMITED
Company Information
for the period from 27 October 2023 to 31 October 2024

Directors

AHLUWALIA, Avneet
DANG, Balvinder Singh

Registered Address

Culverwood Shinfield Road
Shinfield
Reading
RG2 9BE

Registered Number

15242737 (England and Wales)
GKAD HOLDINGS LIMITED
Balance Sheet as at
31 October 2024

Notes

2024

£

£

Fixed assets
Investments3754,996
754,996
Current assets
Debtors47,141
Cash at bank and on hand1,137,126
1,144,267
Creditors amounts falling due within one year5(554,293)
Net current assets (liabilities)589,974
Total assets less current liabilities1,344,970
Net assets1,344,970
Capital and reserves
Called up share capital101
Profit and loss account1,344,869
Shareholders' funds1,344,970
The financial statements were approved and authorised for issue by the Board of Directors on 5 September 2025, and are signed on its behalf by:
DANG, Balvinder Singh
Director
Registered Company No. 15242737
GKAD HOLDINGS LIMITED
Notes to the Financial Statements
for the period ended 31 October 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Interest income
Interest income is recognised using the effective interest rate method.
Dividend income
Dividend income is recognised when the right to receive payment is established.
Current taxation
Current tax is recognised in profit or loss. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

2024
Average number of employees during the year0
3.Fixed asset investments

Investments in groups1

Other loans2

Total

£££
Cost or valuation
Additions202,914552,082754,996
At 31 October 24202,914552,082754,996
Net book value
At 31 October 24202,914552,082754,996

Notes

1Investments in group undertakings and participating interests
2Other loans classified under investments
4.Debtors: amounts due within one year

2024

£
Trade debtors / trade receivables1
Prepayments and accrued income7,140
Total7,141
5.Creditors: amounts due within one year

2024

£
Amounts owed to related parties552,082
Taxation and social security1,611
Accrued liabilities and deferred income600
Total554,293